197 related articles for article (PubMed ID: 19648963)
1. Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer.
Kelly-Spratt KS; Philipp-Staheli J; Gurley KE; Hoon-Kim K; Knoblaugh S; Kemp CJ
Oncogene; 2009 Oct; 28(41):3652-62. PubMed ID: 19648963
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic p27
Calvayrac O; Nowosad A; Cabantous S; Lin LP; Figarol S; Jeannot P; Serres MP; Callot C; Perchey RT; Creff J; Taranchon-Clermont E; Rouquette I; Favre G; Pradines A; Manenti S; Mazieres J; Lee H; Besson A
J Pathol; 2019 Jan; 247(1):60-71. PubMed ID: 30206932
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells.
Kikuchi J; Kinoshita I; Shimizu Y; Oizumi S; Nishimura M; Birrer MJ; Dosaka-Akita H
Br J Cancer; 2008 Dec; 99(12):2013-9. PubMed ID: 19018257
[TBL] [Abstract][Full Text] [Related]
5. The PI3K/Akt/FOXO3a/p27Kip1 signaling contributes to anti-inflammatory drug-suppressed proliferation of human osteoblasts.
Li CJ; Chang JK; Chou CH; Wang GJ; Ho ML
Biochem Pharmacol; 2010 Mar; 79(6):926-37. PubMed ID: 19883628
[TBL] [Abstract][Full Text] [Related]
6. Calpain 2 regulates Akt-FoxO-p27(Kip1) protein signaling pathway in mammary carcinoma.
Ho WC; Pikor L; Gao Y; Elliott BE; Greer PA
J Biol Chem; 2012 May; 287(19):15458-65. PubMed ID: 22427650
[TBL] [Abstract][Full Text] [Related]
7. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines.
Ling YH; Li T; Yuan Z; Haigentz M; Weber TK; Perez-Soler R
Mol Pharmacol; 2007 Aug; 72(2):248-58. PubMed ID: 17456787
[TBL] [Abstract][Full Text] [Related]
8. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
Gesbert F; Sellers WR; Signoretti S; Loda M; Griffin JD
J Biol Chem; 2000 Dec; 275(50):39223-30. PubMed ID: 11010972
[TBL] [Abstract][Full Text] [Related]
9. The death domain-containing kinase RIP1 regulates p27(Kip1) levels through the PI3K-Akt-forkhead pathway.
Park S; Ramnarain DB; Hatanpaa KJ; Mickey BE; Saha D; Paulmurugan R; Madden CJ; Wright PS; Bhai S; Ali MA; Puttaparthi K; Hu W; Elliott JL; Stuve O; Habib AA
EMBO Rep; 2008 Aug; 9(8):766-73. PubMed ID: 18566599
[TBL] [Abstract][Full Text] [Related]
10. Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer.
Tan X; Carretero J; Chen Z; Zhang J; Wang Y; Chen J; Li X; Ye H; Tang C; Cheng X; Hou N; Yang X; Wong KK
PLoS One; 2013; 8(11):e80885. PubMed ID: 24260500
[TBL] [Abstract][Full Text] [Related]
11. Mitogenic regulation of p27(Kip1) gene is mediated by AP-1 transcription factors.
Khattar E; Kumar V
J Biol Chem; 2010 Feb; 285(7):4554-61. PubMed ID: 19959471
[TBL] [Abstract][Full Text] [Related]
12. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
13. NPM/ALK downregulates p27Kip1 in a PI-3K-dependent manner.
Slupianek A; Skorski T
Exp Hematol; 2004 Dec; 32(12):1265-71. PubMed ID: 15588951
[TBL] [Abstract][Full Text] [Related]
14. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression.
Besson A; Gurian-West M; Chen X; Kelly-Spratt KS; Kemp CJ; Roberts JM
Genes Dev; 2006 Jan; 20(1):47-64. PubMed ID: 16391232
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Green S; Trejo CL; McMahon M
Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1.
Collado M; Medema RH; Garcia-Cao I; Dubuisson ML; Barradas M; Glassford J; Rivas C; Burgering BM; Serrano M; Lam EW
J Biol Chem; 2000 Jul; 275(29):21960-8. PubMed ID: 10791951
[TBL] [Abstract][Full Text] [Related]
17. FOXO3a/p27kip1 expression and essential role after acute spinal cord injury in adult rat.
Zhang S; Huan W; Wei H; Shi J; Fan J; Zhao J; Shen A; Teng H
J Cell Biochem; 2013 Feb; 114(2):354-65. PubMed ID: 22930444
[TBL] [Abstract][Full Text] [Related]
18. Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer.
Timmerbeul I; Garrett-Engele CM; Kossatz U; Chen X; Firpo E; Grünwald V; Kamino K; Wilkens L; Lehmann U; Buer J; Geffers R; Kubicka S; Manns MP; Porter PL; Roberts JM; Malek NP
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14009-14. PubMed ID: 16966613
[TBL] [Abstract][Full Text] [Related]
19. K-Ras promotes the non-small lung cancer cells survival by cooperating with sirtuin 1 and p27 under ROS stimulation.
Cheng D; Zhao L; Xu Y; Ou R; Li G; Yang H; Li W
Tumour Biol; 2015 Sep; 36(9):7221-32. PubMed ID: 25894374
[TBL] [Abstract][Full Text] [Related]
20. XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.
Kim J; McMillan E; Kim HS; Venkateswaran N; Makkar G; Rodriguez-Canales J; Villalobos P; Neggers JE; Mendiratta S; Wei S; Landesman Y; Senapedis W; Baloglu E; Chow CB; Frink RE; Gao B; Roth M; Minna JD; Daelemans D; Wistuba II; Posner BA; Scaglioni PP; White MA
Nature; 2016 Oct; 538(7623):114-117. PubMed ID: 27680702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
